Skip to main content

Adhesive Dental

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

RevBio
RevBioMA - Lowell
2 programs
TetraniteN/A1 trial
Tetranite Implant Stabilization MaterialN/A1 trial
Active Trials
NCT04121364Completed20Est. Feb 2023
NCT05535426Unknown15Est. Mar 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
RevBioTetranite Implant Stabilization Material
RevBioTetranite

Clinical Trials (2)

Total enrollment: 35 patients across 2 trials

NCT05535426RevBioTetranite Implant Stabilization Material

Feasibility Study to Assess Outcomes of Immediately Inserted and Restored Dental Implants Using pH-modified Tetranite

Start: Sep 2022Est. completion: Mar 202415 patients
N/AUnknown

Immediate Placement and Stabilization of Dental Implants With Tetranite Stabilization Material in Mandibular and Maxillary Tooth Extraction Sites That Fail to Provide Adequate Primary Stability

Start: Sep 2019Est. completion: Feb 202320 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.